2026年6月4日，北海康成制药有限公司（北海康成-B，股票代码：01228）公布截至2026年5月31日止的证券变动月报。报告显示，公司法定注册股本总额为5,000,000,000股，每股面值USD 0.00001，法定注册股本USD 50,000，与上月保持一致。
报告期内，公司已发行股份总数为595,443,347股，无任何库藏股份，未发生新增发行、回购或注销事宜，股本结构总体保持不变。关于期权与激励计划，当月“首次公开发售后购股权计划”有30,000股期权失效，期末登记持有期权数量为14,097,700股，未触发新股发行。“首次公开发售前股权激励计划”及“首次公开发售后受限制股份单位计划”当月均无新股发行。本期合计新增发行股份为0股，无购回及注销记录。截至本月末，公司股本总数保持稳定。
公司确认严格遵守香港联交所《上市规则》及相关法律规定。公告由董事长薛群博士签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.